Wednesday, July 8, 2020

Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 438 (NASDAQ: $VFF) (CSE: $NOVA.C) (CSE: $LOVE.C) (OTCQB: $MGWFF)


Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 438 (NASDAQ: $VFF) (CSE: $NOVA.C) (CSE: $LOVE.C) (OTCQB: $MGWFF)

Delta, Kelowna, BC, July 8, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:




Today’s podcast overview/transcript:

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

In today’s podcast we look at a few public company announcements.

Village Farms International, Inc. (NASDAQ: VFF) (TSX: VFFannounced that it has executed a definitive agreement with DutchCanGrow Inc., a Netherlands-based cannabis enterprise, to become one of six equal shareholders in DCG owning just under 16% each, with a seventh shareholder owning 5%.  DCG is pursuing the opportunity to become one of a limited number of licensed cannabis growers (up to a maximum of 10) when the Dutch government permits the first legal recreational cannabis market in Europe under its 10-city Experiment to Investigate Closed Cannabis Supply Chains (the "WECG").

If successful in receiving a license from the Dutch government when awarded later this year, DCG plans to construct and operate a specialized cannabis greenhouse facility in the Netherlands and develop, produce and market a variety of safe, high-quality cannabis products to supply this new legalized market. Since 1976 in the Netherlands, a cannabis policy has been in effect regarding cannabis, under which the sale of cannabis at "coffee shops" is tolerated but the cultivation of cannabis is illegal. In 2019, in response to concerns around product safety (ingredients, additives, contaminants) and increasing criminal involvement related to cannabis cultivation, the Netherlands' House of Representatives approved the WECG as an intermediary step to address the lack of quality standards and societal impact of crime related to cannabis.

Under the WECG, which will be in effect for a minimum of four years following a one-year preparation period, all coffee shops in the 10 selected cities (currently 78 coffee shops in total) will be legally required to purchase all of their cannabis exclusively from the approved, federally licensed producers ("LPs").  The supply requirement for the current scope of the WECG is estimated to be approximately 65,000 kilograms of dried cannabis annually. The WECG will be formally evaluated by the Dutch government during the third year of the program, with the potential to expand it from the initial 10 cities to a national program, encompassing all coffee shops in the Netherlands (currently totalling 580).

"Our investment in DutchCanGrow is a momentous first step in leveraging all that Village Farms has accomplished in Canada to become a leader in the burgeoning international cannabis industry," said Michael DeGiglio, CEO, Village Farms International.  "DCG is an outstanding opportunity for Village Farms, not only providing potential access to the very first legal recreational cannabis market in Europe with the possibility of significant expansion within the Netherlands itself, but also to springboard to future legal cannabis opportunities in other markets in Europe, and around the world."

Mr. DeGiglio added, "We are very proud to have been selected by DCG from amongst a number of well-known Canadian LPs that were vying for this unique and exciting opportunity. Village Farms' very own roots as one of North America's largest and most successful greenhouse produce growers go back to Holland.  A number of our most experienced people are multi-generational Dutch growers who brought with them to Village Farms the deep cultural know-how of The Netherlands. To this day, we have strong, enduring relationships with the Dutch growing community, and we are proud to now share the specific expertise we have gained through building Pure Sunfarms into Canada's premiere cannabis supplier.  We look forward to working with this incredible group of partners at DCG, which brings together formidable expertise across a range of disciplines critical to the success of this venture."

Nova Mentis Life Science Corp. (CSE: NOVA) (OTC: LIBFDannounced that Mr. Robert W.E. Laurie has been re-appointed Advisory Board Chair and additionally appointed  Psychedelics Regulatory Advisor.

Robert W.E. Laurie is an international lawyer, qualified in England and called to the British Columbia Bar. Mr. Laurie founded Ad Lucem Law Corporation in Vancouver in 2013 and his legal practice focuses on commercial business, government, regulatory issues, plus charter and constitutional legalities surrounding cannabis and psychedelic plant medicines.

Mr. Laurie serves as a Board Advisor to the Multidisciplinary Association for Psychedelic Studies (MAPS) Canada, Steve DeAngelo's Last Prisoner Project, SPORE Denver and is Legal Advisor to the Heroic Hearts Project UK. He is one of the Founding Partners with Dr. Dennis McKenna of the McKenna Academy of Natural Philosophy. He serves as a Director with Jay DeMerit and Ashleigh McIvor's Rise and Shine Foundation and Rex Weyler's Ecuador Amazon Restoration Project. Mr. Laurie holds an M.A. (Hons) Juris from the University of Oxford (St. Edmund Hall) and B.A. (Hons) in Political Science and International Relations from the University of British Columbia.
Mr. Laurie has been working and advocating tirelessly as a lawyer to improve medical patient access to cannabis, psychedelic and sacred plant medicines and to facilitate the reform of drug laws for the betterment of society. He and his legal practice, Ad Lucem Law Corporation, recently joined Dr. Bruce Tobin's Charter litigation team and the TheraPsil Alliance, who are challenging in Federal Court the constitutional validity of the government's absolute prohibition concerning compassionate medical access to psilocybin. His goal is to help provide more options for doctors and treatments for patients dealing with end-of-life anxiety and depression, and other types of treatment-resistant depression, addiction, and PTSD.

"We are excited that Robert will continue his role as Chair of Nova Mentis' Advisory Board along with the added responsibility of Psychedelics Regulatory Advisor," said Will Rascan, CEO & President of NOVA.  "There are very few individuals with Robert's in-depth experience and contacts in both the psychedelics and cannabis sectors.  With Robert having joined Dr. Bruce Tobin's Charter litigation team, he brings a unique perspective which is evident in his recent Psyched2020 webinar presentation."


Nova Mentis Life Science Corp. (formerly Liberty Leaf Holdings Ltd.) is a Canadian-based, public company whose focus is to build and support a diversified portfolio of health and wellness businesses. Key holdings include its wholly-owned subsidiary, Nova Mentis Biotech Corp., a R&D driven company focused on exploring the anti-inflammatory effects of psilocybin in underexplored metabolic indications such as obesity and diabetes – Just Kush Enterprises, a Health Canada Standard Licensed facility focused on the cultivation of AAAA premium, small batch, terpene rich Kush dominant cultivars cured to perfection.

Cannara Biotech Inc. (CSE: LOVE) (OTCQB: LOVFFannounced today it has closed on its previously announced offer to acquire all of the issued and outstanding shares of Global shopCBD.com Inc. not already owned by Cannara.

Global, through its wholly-owned subsidiary, operates an online e-commerce platform focused on tapping into the U.S. hemp CBD market, offering curated selections of top tier products in a fast, secure and reliable transaction.

Pursuant to the terms of a share exchange agreement dated May 26, 2020 among Cannara, Global and the shareholders of Global, Cannara has acquired 99.8% of the issued and outstanding shares of Global that it did not already own in consideration for the issuance of 23,145,110 common shares of Cannara pro rata to the shareholders of Global at a deemed price of $0.10 per share.

The Payment Shares are not subject to any hold periods under applicable securities laws.
Further information can be found on Cannara's SEDAR profile at www.sedar.com.

Maple Leaf Green World Inc. (NEO: MGW) (OTCQB: MGWFFannounced the launch of a new website for its CBG Hemp Project under the name of its subsidiary, Golden State Green World. The new website is at https://www.gsgreenworld.com. Since the start of the CBG Hemp Project, the Company has been receiving numerous international inquiries about its La Crème CBG products. This website will focus specifically on the CBG Hemp Project and provide purchasing details, information, pictures, progress, and updates for interested parties.
The Company also announced that all 5 greenhouses have been planted to full capacity with La Crème. The plants in the first greenhouse have entered into the flowering stage and will be ready to harvest sometime in August. Some strong and healthy plants have been selected to continue its lineage as the mother plants and this process will continue throughout the season.

Two prospective clients have requested a site tour of the Company’s CBG Hemp Project site at California and have been scheduled for within these 2 weeks. Maple Leaf is extremely optimistic about the medical and therapeutic potential of CBG as more research is conducted and the awareness grows. The Company is thrilled to be emerging as one of the few high quality CBG cultivators in the United States and one of the few growers cultivating La Crème.

For updates regarding the California CBG Hemp Project, please visit https://www.gsgreenworld.com.

For further information and updates regarding the Company, please visit www.mlgreenworld.com.

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp


To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy:

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.


Download our Mobile App for iPhone and Android 

Contact Investorideas.com
800 665 0411


  




Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory


Tuesday, July 7, 2020

Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 437 (TSX: $FAF.TO) (OTC: $EDXC) (CSE: $XCX.C) (TSX: $VIVO.TO)


Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 437 (TSX: $FAF.TO) (OTC: $EDXC) (CSE: $XCX.C) (TSX: $VIVO.TO)

Delta, Kelowna, BC, July 7, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:




Today’s podcast overview/transcript:

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

In today’s podcast we look at a few public company announcements.

Fire & Flower Holdings Corp. and its wholly-owned subsidiary Fire & Flower Inc. (TSX: FAF) (OTCQX: FFLWF), announced the openings of its first two cannabis retail stores adjacent to Circle K locations in the province of Alberta.

Through this initiative, Fire & Flower is expected to benefit from high traffic Circle K locations to deliver an unprecedented level of convenience to cannabis customers, maximizing the benefit of the Spark PerksTM program and Spark FastlaneTM online ordering services at conveniently located stores.

The two stores in Calgary and Grande Prairie are expected to be the first of additional opportunities to co-locate cannabis retail stores in the future. The co-located stores will be owned and operated by Fire & Flower and are separate from the adjacent Circle K in accordance with all applicable regulations. It is anticipated that the Grande Prairie store will open the week of July 6, 2020 and it is anticipated the Calgary store will open the week of July 13, 2020.

Information on the co-located stores will be available on the Fire & Flower website at www.fireandflower.com/locations/.

"As we continue to build our relationship with Alimentation Couche-Tard, Fire & Flower is very pleased to be embarking on this initiative together," shared Trevor Fencott, Chief Executive Officer of Fire & Flower. "We believe that combining convenient pickup locations with digital engagement offered by the Hifyre platform and Spark Perks program presents our customers with a differentiated value proposition in an increasingly competitive cannabis retail market. This approach to innovation in omni-channel and convenience-oriented cannabis retail differentiates Fire & Flower and positions us well to capitalize on both domestic and international opportunities."

Endexx® Corporation (OTC: EDXCannounced the e-commerce launch of RubyBees™ Hemp Infused Honey. RubyBees™ is now available in 950mg and 120mg jars for purchase on CBD Unlimited’s website.

Peter Boyer created RubyBees Hemp Honey when he was first introduced to CBD Unlimited’s hemp-derived CBD, an active ingredient derived directly from the hemp plant that exhibits soothing properties, as a way to ease the symptoms of his daughter. Longtime Endexx shareholder, Richard Steinhart, has long believed in the therapeutic benefits of CBD and suggested Boyer consult his daughter’s doctor about trying CBD sublingual oil alongside the medication she already takes for her cerebral palsy and epilepsy.

“As a father with a special needs daughter, I was searching for a way to help improve Ruby’s life. After working with CBD Unlimited and using their hemp-derived isolate, the positive change in Ruby’s everyday life was apparent. Utilizing honey as the delivery system and implementing the knowledge of proper dosages provided by the CBDU team, the tasty treat doubles as an effective way to enjoy the benefits of CBD. With their expansive knowledge and expertise in the industry, working with CBD Unlimited was a clear step in the right direction. We at RubyBees are eager and excited to be a part of such an incredible industry and to be working with a company focused on improving the lives of the people we care for,”  commented Founder of RubyBees, Peter Boyer.

Great for coffee, tea, power drinks, toast spread, or for cooking, RubyBees Hemp Honey products are made with clover honey and infused with 10mg of hemp-derived isolate per serving while containing zero percent THC, no gluten, and no GMO’s. RubyBees Hemp Honey is also available in honey stick format, lab tested, and certified.

“We at CBD Unlimited are incredibly grateful and excited to offer our CBD in a product from a company as inspiring as RubyBees,” commented Todd Davis, CEO and Chairman of Endexx. “Whether the product is used as a therapeutic treatment or as a pick-me-up snack, we are confident that the RubyBees Hemp Honey will soon become a consumer favorite and continue to make waves in the CBD industry.”

To purchase RubyBees Hemp Infused Honey, please follow this link: https://www.cbdunlimited.com/our-products/rubybees-hemp-honey-950mg/

AMP German Cannabis Group Inc. (CSE: XCXannounced further to its June 5, 2020 news release that The Office of Medical Cannabis ("OMC"), the government organization of the Netherlands for distribution of medical cannabis products, has notified AMP that it will resume exports of EU-GMP medical cannabis to Germany. The OMC will deliver 3,000 grams per month to each German importer due to the high demand and restricted supply currently available for Germany.

AMP has ordered Bedrocan International branded products to be exported by OMC on a monthly basis beginning July 2020. AMP has received all the required licenses to import irradiated cannabis flowers from the Dutch and German government authorities.

Dr. Stefan Feuerstein, Director and President of AMP, commented: "All pieces of the puzzle have come together with the start of our first import. We will be booking our first revenue from the sale of our Bedrocan products this month and hope to receive a higher amount from the Netherlands in August 2020. We are also on track to sign a definitive supply agreement with a Canadian supplier and will be adding pharmaceutical distribution partners that focus on medical cannabis exclusively to our distribution network covering Germany. Our next step is to increase import volumes from Canada in conjunction with developing AMP's medical cannabis brands for the German market."


VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF), a leading provider of premium cannabis products and services and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited, ABcann Medicinals Inc. and Harvest Medicine Inc., who provided an update on its global medical business, which operates in Canada, Germany and Australia.

"One of our top strategic priorities is to focus on the global medical cannabis market, directly servicing tens of thousands of patients and investing in product development initiatives that prioritize high-quality novel products," said Barry Fishman, CEO of VIVO.  "We've recently made significant progress on a number of key initiatives, which will help solidify our market presence as a company that is committed to delivering solutions for patients and healthcare professionals on an international scale."

VIVO believes that significant growth in medical cannabis utilization will be driven by several factors including:
1. Accelerating legalization of medicinal cannabis globally
2. Mounting real-world and clinical evidence of therapeutic benefits
3. Increasing clinician adoption of medical cannabis as a viable therapeutic option
4. Growing reimbursement by governments and third-party payors
5. Improving patient and healthcare practitioner awareness, education and access
6. Introducing new medical-grade, precise-dosed, stable formulations
7. Removing the sales tax on medical cannabis in Canada
The Company is pleased to announce several initiatives that advance the Company's impact within the global medical cannabis market.

Shoppers Drug Mart Partnership
VIVO has entered into both a product supply agreement and a clinic services agreement with Medical Cannabis by Shoppers™.  As previously announced, VIVO's two licensed producers will offer a broad portfolio of Canna Farms™ and Beacon Medical™ branded medical cannabis products through the Medical Cannabis by Shoppers™ online sales platform, including its latest Cannabis 2.0 offerings such as chocolates and extracts making these products accessible to Medical Cannabis by Shoppers™ patients across Canada.

Under the terms of the clinic services agreement, VIVO's subsidiary, Harvest Medicine, will provide cannabis education services to patients who are appropriate candidates for cannabinoid-based products available from Medical Cannabis by Shoppers™ and provide consulting services to its Cannabis Care team.

Launch of Beacon Medical Oils in Australia

VIVO's subsidiary, Beacon Medical Australia, has entered into a supply agreement with MediPharm Labs Australia to purchase pharmaceutical quality (GMP certified) cannabis oils for the Australian market.

As previously announced, under the agreement MediPharm Labs Australia will supply its full range of GMP-certified, formulated CBD and THC cannabis oils to Beacon Medical Australia for further distribution under the Beacon Medical branding.  The addition of cannabis oils to Beacon's Australian portfolio is an important step towards capturing market share in Australia's growing medical cannabis market.

Veterans House Partnership

VIVO has entered into a collaboration agreement with Veterans House ("Veterans House"), under which the Company will provide sponsorship and support to joint programs for Canadian Armed Forces veterans. Veterans House is a federally registered non-profit organization that provides veterans suffering from mental illness and operational stress injuries such as post-traumatic stress disorder, with access to counseling and peer support programs.

"Canna Farms is a long-standing supporter of veterans, providing access to leading medical cannabis products and programs," said Fabian Henry, Senior Director of Operations at Veterans House. "The team at VIVO has shown an ongoing commitment to Canadian veterans and we look forward to working more closely together to serve this community."

"We are proud to be associated with Veterans House," said Mr. Fishman. "Our veterans have dedicated their lives to defending the rights and freedoms we have in Canada. We are honoured to play an important role in enhancing the quality of life for our veterans."

Medical Product Line Expansion

VIVO also introduced softgel capsules, with several cannabinoid concentrations
available, through its Canna Farms on-line medical marketplace in the coming weeks. Softgel capsules provide patients with a convenient format to ingest cannabis in a precisely dosed format.

The introduction of softgels follows the successful launch of VIVO's Cannabis 2.0 product offerings (including chocolates and extracts) into the Canadian medical market, increasing choice for the Company's more than 20,000 registered patients.

The Canna Farms store now carries six leading medical brands including GTEC, Aqualitis and Pure Sunfarms. "Our web-based medical store continues to be a key point of connection for Canadian patients to conveniently access medical cannabis products," said Daniel Laflamme, President of Canna Farms. "Having a consistent supply of medical products has been an industry-wide concern and we continue to enhance our manufacturing processes and relationships with other established high-quality LP partners, to supply our medical patients with a wide range of product options."

Product Development Progress

VIVO moved into the next stage of product innovation with partner Pharmascience Inc., a global pharmaceutical company based in Montreal, for the development of a line of specific medical cannabis formulations produced under pharmaceutical quality standards intended to maximize the benefit to patients.

"Healthcare professionals and patients are increasingly searching for precisely-controlled, high-quality, standardized dosage forms of medical cannabis. VIVO has invested in several product development projects with proven partners experienced in formulating complex medical products," stated Mr. Fishman.

EU-GMP Follow-up Audit Completed

A follow-up EU-GMP audit was recently completed at VIVO's ABcann Medicinal facility in Napanee. This is an important step towards EU GMP-certification and is a requirement to export medical cannabis products from Canada for sale in Germany and other European countries.

Real-World Evidence Collaboration

The Company entered into a partnership with privately held Reformulary Group, an innovative healthcare company dedicated to helping Canadians make sense of medicine (prescription drugs and medical cannabis). VIVO has agreed to provide clinical support, through the Company's Harvest Medicine clinics, to patients who access Reformulary Group's Cannabis Standard™ platform. Cannabis Standard is an ecosystem of expert recommendations, patient-powered tools, and independent information to help Canadians and healthcare professionals make smarter, more informed decisions about choosing medical cannabis.

"Cannabis Standard™ applies the same formula that we've used so successfully on the prescription medication side. We gathered a panel of independent medical experts, conducted a comprehensive review all of the available evidence globally, and created user-friendly tools to help Canadians navigate the medical cannabis space," said Helen Stevenson, Reformulary Group founder and CEO. "At its core, Cannabis Standard™ is about helping patients benefit from and contribute to the growing base of medical cannabis research, and we look forward to working closely with the team at VIVO to advance patient outcomes."

VIVO has also engaged Strainprint Technologies™, a leader in cannabis data and analytics, to examine real-world evidence of its products, linking utilization and efficacy for several of the leading indications treated with medical cannabis from thousands of patients. This evidence is being used by healthcare professionals to assist in determining optimal treatment options and by patients to help navigate their medical cannabis journey. VIVO is the first Canadian LP to provide this valuable information on its products to key stakeholders.

Patient Support Under COVID-19

Health Canada recently announced that due to COVID-19, it is temporarily extending the expiry date of registrations by six months for patients who are having difficulty accessing their health care prescriber to obtain a new medical document.
Since Harvest Medicine temporarily moved its entire clinic operations to telemedicine in late Q1 2020, the feedback from patients and prescribing clinicians adapting to virtual visits has been overwhelmingly positive.

"Not only has there been no lapse in ongoing care for our patients during COVID-19, but our dedicated team was able to scale up to meet increased patient demand for visits on our HMED Connect  mobile application platform which have more than tripled during the pandemic," stated Carole Chan, President of Harvest Medicine. "We understand the importance of in-person consultations for certain patient populations, and we will continue to offer this option when clinics re-open in the near future with enhanced protocols to keep patients and staff safe."

VIVO is confident that it will benefit from Health Canada's recent announcement and Harvest Medicine's ability to continue to provide high-quality patient services during COVID-19.

Product Identification Enhancement

VIVO, through its global Beacon Medical™ brand has simplified its consumer-facing product naming conventions and added Product Identification Numbers (PINs) to its core Canadian offering to better support doctors, pharmacists and patients in navigating medical cannabis. "Introducing PINs will enable Canadian insurers to more easily navigate our products," commented Matt Patterson, Vice President of Medical Strategy.

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp


To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy:

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.


Download our Mobile App for iPhone and Android 

Contact Investorideas.com
800 665 0411


  





Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory


Thursday, July 2, 2020

Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 436 (TSXV: $KHRN.V) (OTC: $EDXC)


Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 436 (TSXV: $KHRN.V) (OTC: $EDXC)


Delta, Kelowna, BC, July 2, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:




Today’s podcast overview/transcript:

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

In today’s podcast we look at a few public company announcements.

Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF), a vertically integrated cannabis leader with core operations in Latin America and Europe, announced that it has signed a distribution deal for its Kuida™ CBD cosmeceutical brand with Red Yellow Red, a leading EU distributor of cosmetic products. Kuida skin and body care products for women will be distributed by Red Yellow Red through four major multinational drug store health and beauty distribution groups in Spain.

"The European skincare market is the largest in the world, and as we scale up our EU activity this agreement immediately expands our Kuida footprint into a €1.5 billion market. Red Yellow Red have a large and compelling distribution network, and a robust sales and education program that aligns with our proven market entry approach to help more consumers integrate Kuida into their daily skincare regimen," comments Tejinder Virk, President, Khiron Europe.

Red Yellow Red is a specialized distributor of cosmetic, beauty, lifestyle and personal wellbeing products operating in Spain and Portugal, with access to 20,000 points of sale through four drug store health and beauty distributor groups. To support Kuida sales and brand image, Red Yellow Red will initiate training of retail staff on the current Kuida portfolio, the benefits of cannabidiol (CBD), as well as the brand's unique CBDERM™ technology.

Further Red Yellow Red information can be found at http://www.redyellowred.es/.

"At Red Yellow Red we look to bring innovative and first to market products to our distribution partners and in turn, consumers. Kuida fits that model and is an established skincare brand with an attractive CBD product line that, supported by our training and education program, can have strong appeal across our Spanish pharmacy network," comments José Luis Ganado, Managing Director, Red Yellow Red.

Ikänik Farms, Inc. announced that it has purchased all issued and outstanding shares of Delta 9 Corporation Mexico S.A. de C.V ("D9C"), based in Coyoacán, Mexico. D9C's legal representative is permitted to import and register cannabis seeds for cultivation through the legalized Amparo process. The Company intends to contract-produce for national and international pharmaceutical cannabis and hemp-derived CBD clients.

"I am very excited to welcome D9C and its team of scientific, legal, and regulatory specialists who have been exemplary leaders, shepherding the cannabis legalization process, and providing Ikänik the opportunity to be a 1 of 1 in Mexico", said Brian Baca, CEO of Ikänik Farms, Inc.

D9C is the exclusive Amparo representative to import, cultivate, and produce products derived from cannabis and hemp for national and international markets.
Borja Sanz de Madrid, President of Ikänik International, Inc. further emphasized, "We are proud to participate in this historic moment for Mexico. It will be our honor bringing pharmaceutical cannabis Hecho en Mexico para el mundo"

Upon D9C's legal representative completing the seed importation and registration process, cultivation and facility construction will commence, providing employment opportunities and social support in the communities it serves.

This acquisition marks a significant milestone for the Company, as it continues to grow its multi-national operating presence and prepares to complete a public listing on the Canadian Securities Exchange.

Endexx Corporation (OTC:EDXC), a lifestyle company focused on the intersection of science, compliance, and formulation of innovative phytonutrient-based food and nutritional products, today announced the launch of the Company’s newest product line, Phyto-Drops CBD for Pets. The new line complements the PhytoBites soft chews introduced in 2016 to build a strong suite of Pet products.

“We continued to build, research, and develop new products as R&D is rooted in the DNA of our Company,” commented Endexx Chief Executive Officer and Chairman, Todd Davis. “Our drops are formulated using all-natural ingredients and flavored with natural oils and no sugar. We are thrilled to bring this product to market as our pet division continues to lead product demand. With the shift in consumer buying preferences amid the pandemic, this product line will initially be available online through our website followed by our wholesale network. Products with all-natural ingredients and no sugar provide assurance of quality and purity for dogs, cats, and their families.  Our complete formulations help to improve our customer’s and their pet’s “Quality of Life”. We continue to remain focused on consumer-centered innovation and this product launch is a reflection of our commitment to our customers.”

Phyto-Drops CBD for Pets are now available in 30ml and 10ml formats on CBD Unlimited’s e-commerce website. CBD Unlimited oils are free from any synthetic additives and each product is lab tested to ensure quality of the product. Phyto-Drops CBD for Pets is formulated for minimal dosing and long-lasting results.

To purchase Phyto-Drops CBD for Pets, please visit https://www.cbdunlimited.com/our-products/buy-cbd/pets/

Hemp, Inc. (OTC: HEMPannounced its support for new guidelines from the U.S. Treasury Department’s Financial Crimes Enforcement Network.
“These guidelines help clarify how hemp should be treated and operate in the banking space. This is an important move by the US Department of Treasury in support of the American hemp industry,” said Hemp, Inc. CEO Bruce Perlowin. “A lot of the hurdles that the hemp industry faces come from stigma and misinformation; in the past that has informed policy. Fortunately, the power and promise of hemp is coming to light in the mainstream and we are gaining lots of support from everyday people, regulatory professionals and policy makers.”
The Financial Crimes Enforcement Network’s (FinCEN) new guidelines emphasize that hemp businesses must be treated equally. This means that financial institutions are expected to monitor the transactions made by hemp-related businesses as they would for other clients. The FinCEN instructs the financial institutions to follow standard procedures and file a SAR (Suspicious Activity Report) only if they have been made aware of suspicious activity.  
According to the FinCEN, suspicious activity could include:
       A customer appears to be engaged in hemp production in a state or jurisdiction in which hemp production remains illegal.
       A customer appears to be using a state-licensed hemp business as a front or pretext to launder money derived from other criminal activity or derived from marijuana-related activity that may not be permitted under applicable law.
       A customer engaged in hemp production seeks to conceal or disguise involvement in marijuana-related business activity.
       The customer is unable or unwilling to certify or provide sufficient information to demonstrate that it is duly licensed and operating consistent with applicable law, or the financial institution becomes aware that the customer continues to operate after a license revocation, or inconsistently with applicable law.
Additionally, FinCEN provided clarification on requirements for businesses that are involved in both hemp and marijuana, stressing the importance of keeping the proceeds of the businesses separate and ensuring that the customer and its financial institution are able to distinguish which proceeds are marijuana-related and which are hemp-related.
Those interested in King of Hemp™ pre-rolls or hemp-derived CBD tinctures should visit www.kingofhempusa.com or email sales@kingofhempusa.com






Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp


To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy:

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.


Download our Mobile App for iPhone and Android 

Contact Investorideas.com
800 665 0411


  




Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory